About the Journal

The Chemical Biology Letter is a peer reviewed international journal that provides a rapid forum for publication of quality original research at the interface of chemistry and biology. Chemical biology letters covers the scientific ideas and approaches of chemistry, biology and allied interdisciplinary areas such as medicinal chemistry, drug discovery, drug delivery, pharmaceutical chemistry, biochemistry, biosensor, protein chemistry, biological chemistry, biomolecules, bio-technology, biomedical, molecular biology and other allied areas covering chemistry and biology for the better understanding of biological phenomenon at molecular level. The journal accepts research articles from the community of chemical biologists.

About CBL

The Chemical Biology Letters is a top-tier venue for discoveries at the interface of chemistry and biology, chemical biology, synthetic biology, and in basic and applied biomedical research covering recent advances in drugs and therapeutics development. The CBL:

  • would provide all contents online for wide circulation and get contents indexed in different scientific content databases.
  • provides free access to all of its research articles for one or more months for each issue,
  • would deposit published research articles in different databases and would satisfy the NIH Public Access Policy guidelines.
  • is an ideal home for authors seeking the broadest audience for their most important work.

The journal is led by Editors and supported by Editorial Advisory Board of peer scientists from various reputed universities, research institutes and other reputed Medical Research Institutes whose depth and experience ensure fair and competent peer review.

Sending your work to the CBL

The journal considers research submissions in several categories. The CBL receives submissions only through its website; submissions by mail or e-mail will be returned.

Do you have a question about a manuscript you've already submitted?

  • When a manuscript is received and confirmed by the CBL, an acknowledgment is sent via e-mail to the corresponding author. For any communication with us, please reference the tracking number assigned by the CBL noted in the acknowledgment.
  • In order to avoid confusion regarding correspondence, inquiries, and decisions, the CBL will typically communicate only with those who are designated as corresponding authors during the submission process.

Manuscript submitted and processed for reviewing can't be withdrawn. If authors do not respond to emails for the reviewed and accepted manuscript, then the article will be published by the journal in unedited format with a note 'withdrawn by authors' by no response.

Unique IDs for Articles: The journal is currently using URN number for the published articles (however, this is currently meant for internal use by the journal). The journal will process the assigning of DOI (Digital Object Identifier) to articles (including previously published ones) once the journal is indexed in Web of Science (Clarivate) as it helps in providing the correct citations records for the published articles.

Publication Ethics and Publication Malpractice Statement

The Journal ‘Chemical Biology Letters’ and its Publisher ‘ScienceIn’ follows the best practices in evaluation of contents, processing of manuscripts and publishing thereof. The Journal and Publisher essentially follows the code of conduct defined by Committee on Publication Ethics (COPE) for Journal Editors (Code of Conduct and Best Practices Guidelines for Journal Editors listed in COPE guidelines and Publisher (the Code of Conduct Journal Publishers listed in COPE page COPE site

Further, the journal publishes biomedical reports, so the journal adheres and follows the guidelines defined for publication in medical journals by International Committee of Medical Journal Editors (ICMJE) in its document ‘Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals’ provided on link http://www.icmje.org/recommendations and World Association of Medical Editors (WAME) on its webpage http://www.wame.org/

The Authors, Reviewers and Editors need to adhere and follow the code of conduct on ethical practices defined at above mentioned links in the respective roles.


The manuscript processing involves following stages


In addition, general instructions and help pages on ‘Integrated Science’ for Authors, Reviewers and Editors should be referred for brief general conduct


Each author who submits (and willing to publish in the journal) the manuscript, should read the ethical guidelines for submission and publication of work in scientific and medical journals (listed on above links). Particularly, manuscripts must be plagiarism free. Any Animal study reported should have been performed with approval of respective institutional ethical committee and statement thereof should be included in manuscript.

Author Guidelines for manuscript preparation and submission details are provided under Author Guidelines (See submission link).

The authors should refer the publishing ethics or 'Code of conduct' and 'conflict on interest' guidelines on the link: https://pubs.thesciencein.org/authors-code-of-conduct/


The journal uses ‘Single Blind Review’ of the manuscripts, the reviewers must maintain confidentiality during reviewing and post review of manuscript. The manuscript work should be evaluated in respective fields of expertise and detailed feedback and recommendation should be provided to editors. The general code of conduct defined in links below should be referred to and followed while reviewing and providing feedback.

The ethics guidelines/code of conduct details for reviewers can be referred at https://pubs.thesciencein.org/reviewers-code-of-conduct/


All the editors should handle the assigned manuscripts by observing fair processing of submissions, editorial independence, confidentiality, and rational decision making within a stipulated time framework with the feedback obtained from independent reviewer/experts in the field of work covered in the respective manuscript. A detailed code of conduct mentioned in COPE reference documents and ScienceIn page https://pubs.thesciencein.org/editors-code-of-conduct/ should be adhered to.


The Publisher ‘ScienceIn’ handles the unethical publishing cases. In cases of alleged or proven scientific misconduct, fraudulent publication or plagiarism, the publisher, in close collaboration with the editors, will take all appropriate measures to clarify the situation and to amend the article in question. This includes the prompt publication of an erratum, clarification or, in the most severe case, the retraction of the affected work. The publisher, together with the editors, shall take reasonable steps to identify and prevent the publication of papers where research misconduct has occurred, and under no circumstances encourage such misconduct or knowingly allow such misconduct to take place.

Access to journal content: The publisher is committed to the permanent availability and preservation of scholarly research. The online and digital contents are preserved by the Publisher by maintaining its own digital archive and would also ensure accessibility by partnering with other digital archiving organizations. Most of the journal contents are archived in the Print form as well.